drug
34 articole · RSS
Ozone sale on finishing straight
Shareholders of drug maker Ozone are negotiating the sale of the company with American manufacturer Valeant, but are also considering integrating it into A&D Pharma, another business they co...
Antibiotice invests 8m euros in production
Drug producer Antibiotice Iasi, one of the leading players in the industry, has budgeted investments worth 7.5-8 million euros to expand the tablet manufacturing capacity in the 2008 - 2009...
Top 10 drug distributors' profit margins below 2%
Last year saw the main domestic drug distributors' profit margins fall dramatically, while two top ten players registered their first losses. The main players in the drug distribution sector...
Drug makers tap into 24m-euro dermocosmetics market
Forced by unfavourable conditions on the pharmaceutical market, producers, distributors and retailers are in search of alternatives to boost profit margins, and one solution is dermocosmetic...
Labormed sale takes drug market deals to over 650m euros
LaborMed Pharma, the drug manufacturer, owned by five Romanian entrepreneurs, has been acquired by Advent investment fund in a deal estimated to be worth approximately 120 million euros, acc...
Romanian drug consumption to rapidly catch up with Western Europe
Romanians last year spent four times less than West Europeans on drugs per person. The Romanian pharmaceutical market will witness average annual growth of 13.3% by 2010, according to estima...
Europharm closes six drug warehouses due to mark-up cuts
Drug distributor Europharm, held by the UK giant GlaxoSmithKline (GSK), leader of the Romanian pharmaceutical market, will close down 6 of its 17 warehouses, with the company having the most...
Domestic drug makers to challenge foreign markets
There are only a handful of Romanian drug exporters and few domestically manufactured products are present on foreign markets. Nevertheless, the main domestic producers seem set to exploit a...
Farmacom, 23.5m euros from drug distribution
Brasov-based Farmacom, specialising in drug distribution, estimates a 23.5 million-euro (80 million-RON) turnover, up 25% against 2006, when this indicator stood at around 18.8 million euros...